Experience

Medicenna Therapeutics Corp.

• Canada
• Biotechnology Research
• 1 - 100 Employee

• Chief Business Officer

  • Aug 2023 - Oct 2023

  Boston, Massachusetts, United States Led the business development and corporate strategy. Charged with building the future leadership team in the Greater Boston area.



OncoOne

• Austria
• Biotechnology Research
• 1 - 100 Employee

• Chief Business Officer and US General Manager

  • Sep 2021 - Aug 2023

  Cambridge, Massachusetts, United States Led the business development, partnering, commercialization, and US operations of OncoOne. OncoOne is a preclinical biotech company dedicated to developing innovative, best-in-class therapeutics against the macrophage migration inhibitory factor, of MIF, to treat patients with solid tumors and inflammation. OncoOne's global headquarters is in Vienna, Austria -- I lead the US operations out of Boston.



Biogen

• United States
• Biotechnology Research
• 700 & Above Employee

• Early & External Product Commercialization Lead, Alzheimer's Disease, Neuropsychiatry & Emerging TAs

  • 2019 - Sep 2021

  Cambridge, MA Led the team to provide commercialization insights and strategy development for Biogen’s early phase Alzheimer’s disease and Dementia, Neuropsychiatry, Ophthalmology, and Emerging Therapeutic Area portfolio assets including acute neurology (stroke), epilepsy, and pain. Responsible for leading the commercial insights into external business development partnerships and in-licensing opportunities. Serve as the Commercial Lead for the CD20 franchise partnership with Genentech.



Indivior

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Head of Marketing and Global Commercial Leader

  • 2017 - 2018

  Richmond, Virginia Led the formation of the marketing team for Indivior’s Behavioral Health Franchise. Responsible for the PERSERIS launch strategy, tactical planning, and marketing campaigns. Also led the global strategic efforts in next indications, formulations, and business development opportunities to build the behavioral health franchise.



Shire

• Japan
• Biotechnology Research
• 700 & Above Employee

• Oncology New Products Planning Commercial Lead

  • 2015 - 2017

  Cambridge, Massachusetts Led the commercialization insights for the Symphogen partnership for immuno-oncology checkpoint inhibitors, and the Precision Biosciences CAR-T program as well as for Baxalta and Shire’s internally developed clinical stage oncology assets. Led the commercial insights and market assessments for Shire Oncology's business development opportunities.



Regeneron

• United States
• Biotechnology
• 700 & Above Employee

• Global Oncology Launch HCP Marketing

  • 2011 - 2014

  East Coast Responsible for leading the marketing efforts for ZALTRAP through development, launch, and beyond. Provides sound strategic and tactical oncology marketing expertise coupled with building the requisite alliance infrastructure to prepare Regeneron for its first oncology product launch. Collaborates with alliance partner to jointly create launch strategies and implement key tactical plans necessary for global promotional activities. Serves as the Regeneron champion for the brand, represents… Show more Responsible for leading the marketing efforts for ZALTRAP through development, launch, and beyond. Provides sound strategic and tactical oncology marketing expertise coupled with building the requisite alliance infrastructure to prepare Regeneron for its first oncology product launch. Collaborates with alliance partner to jointly create launch strategies and implement key tactical plans necessary for global promotional activities. Serves as the Regeneron champion for the brand, represents Regeneron on alliance cross-functional committees, and collaborates to develop and execute commercialization plans with key Sanofi-Aventis U.S. and global affiliate functional leads. Show less



AVEO Oncology

• United States
• Biotechnology Research
• 100 - 200 Employee

• Tivozanib Co-Program Executive and Market Development Lead

  • 2007 - 2011

  First company commercial hire responsible for leading all aspects of pre-launch marketing, market development, KOL relationships, medical affairs, publication planning, market research, and competitive intelligence to support tivozanib, AVEO's lead asset -- an oral pan-VEGF TKI approved in EMEA and more recently in the US as FOTIVDA.



Bristol Myers Squibb

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• US Launch Marketing - Oncology

  • 2005 - 2007

  Led the US HCP marketing and KOL outreach efforts for the launch of the Head & Neck Cancer indication of ERBITUX (Cetuximab).



Johnson & Johnson

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Sales/Sales Leadership/Global Strategic Marketing

  • 1995 - 2005

  Greater Boston Area Led the global launch of REMINYL (galantamine), the third acetylcholinesterase inhibitor for the treatment of patients with Alzheimer’s disease. Led the South Jersey District to the #1 ranking for the promotion of RISPERDAL and launch of RISPERDAL CONSTA, the first long-acting injectable atypical antipsychotic. Led the global forecasting for the Hematology and Oncology Franchises, including the business development efforts to in-license new cancer assets.



US Army

• United States
• Armed Forces
• 700 & Above Employee

• Captain

  • 1990 - 1995

  Frankfurt Am Main Area, Germany Led teams of 55 and 66 soldiers to new heights of combat readiness. Received the Meritorious Service Medal for supervising the largest overseas pay operation. Recognized as a V Corps Distinguished Leader.